Despite decades of research, multiple myeloma remains an incurable disease. A wide array of therapies, such as proteasome ...

During a live event, Hans Lee, MD, and participants discussed potential approaches to modifying frontline multiple myeloma ...

SCIENTISTS have discovered a new way to track blood cancer, even when traditional tests miss it. A whole-body MRI scan can ...

Scientists have found a new way to find tiny traces of cancer that could help “revolutionise” care for patients with a ...

Giving patients a whole-body MRI scan can detect minuscule amounts of myeloma, also known as minimal residue disease, even ...

Giving patients a whole-body MRI scan can detect minuscule amounts of myeloma, also known as minimal residue disease, even ...

A Royal Air Force pilot diagnosed with blood cancer was able to return to flying jets after being given a new scanning ...

Meta: In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic ...

New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...

The new direct-to-consumer ad signals J&J’s confidence in its capacity to meet demand for the cell therapy after earlier ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...